American Innovation and R&D Competitiveness Act of 2023 This bill eliminates the five-year amortization requirement for research and experimental expenditures, thus allowing continued expensing of such expenditures in the taxable years in which they are incurred.
Maddy summaryHR 2724, the Sister City Transparency Act, requires the Government Accountability Office (GAO) to study sister city partnerships between U.S. local governments (like cities or counties) and foreign communities in countries scoring 45 or below on Transparency International’s Corruption Perceptions Index. The study will examine partnership criteria, activities, economic outcomes, transparency practices, and potential risks like foreign espionage or economic coercion. It will assess how these partnerships affect freedom of expression, U.S. security interests, and vulnerability to malign activities. The GAO must submit a report to relevant congressional committees within six months, including findings and recommendations. This bill does not change existing partnerships but mandates a review of their transparency and security implications.
Maddy summaryHJRES 27 is a congressional resolution seeking to block a federal rule that redefined which waterways fall under the Clean Water Act's protections. It targets a rule submitted by the Army Corps of Engineers, Department of Defense, and Environmental Protection Agency (EPA) on January 18, 2023, which aimed to revise the "Waters of the United States" definition. The resolution would formally disapprove this rule under a specific federal procedure (Chapter 8 of Title 5), preventing it from taking effect. This would directly affect how federal agencies regulate pollution and development near water bodies, including wetlands and smaller streams.
Maddy summaryHR 2665 delays Medicaid payment reductions for safety net hospitals by two years, changing the effective date from 2024 to 2026 under Section 1923(f)(7)(A) of the Social Security Act. This bill directly affects hospitals that serve high numbers of low-income and uninsured patients, providing them with additional time before facing reduced federal Medicaid payments. The key mechanism is a technical amendment to existing law, postponing an already scheduled payment adjustment without altering funding levels or eligibility. As a procedural bill, it does not create new programs or change hospital requirements.
Maddy summaryHR 2647, the Restore Public Health Institution Trust Act of 2023, requires the U.S. Comptroller General to produce a report within 120 days of enactment examining the Centers for Disease Control and Prevention's (CDC) public health messaging and guidance during the pandemic. The report must analyze the data used by the CDC, assess how inconsistent messaging affected public trust and vaccine uptake (including for school-age children), and evaluate potential influence from outside groups like teachers unions. It will also provide recommendations to improve the CDC's future communication and decision-making processes. This bill does not change CDC policies but mandates an independent review to address concerns about public health communication. The report will be submitted to specific congressional committees focused on health, education, and oversight.
Maddy summaryHR 2620, the Federal Firearms Licensee Protection Act of 2023, increases penalties for crimes targeting firearms licensees. It amends Section 924 of Title 18 to impose mandatory minimum sentences of 3 years for burglaries or 5 years for robberies committed at the business premises of licensed firearms dealers, manufacturers, or importers. The bill specifically targets violations of Section 922(u), which prohibits unauthorized access to these premises, and adds "attempts to do so" to the penalties. This directly affects licensed firearms businesses by strengthening legal protections against theft or violence at their locations. The law creates clearer, harsher consequences for crimes committed during burglaries or robberies at these specific business sites.
Maddy summaryHR 1839, the Combating Illicit Xylazine Act, makes the illicit use and distribution of xylazine a federal crime by adding it to the Controlled Substances Act. The bill broadly defines xylazine to cover numerous chemical variants and prohibits human use or non-licit distribution, while preserving legitimate veterinary and pharmaceutical uses. It requires tracking xylazine in drug supply chains and mandates two reports to Congress within 1 and 4 years on its prevalence, sources, and whether it should be rescheduled. The bill directly affects individuals distributing or using xylazine illicitly, including as an additive to drugs like fentanyl, and aims to address its public health risks. Congress declared illicit xylazine an "emerging drug threat" under existing law.
Maddy summaryHR 2483, the School Security Enhancement Act, amends the Elementary and Secondary Education Act to allow local schools to use existing federal funds for specific security improvements. It permits spending on measures like metal detectors, crisis notification systems, bullet-resistant doors, and access control technology, provided they have evidence-based effectiveness. The bill explicitly prohibits using these funds for firearms or firearm training (Section d(1)), while clarifying it doesn’t override other laws permitting firearms (Section d(2)). This directly affects schools receiving ESEA funds by expanding eligible security investments under Section 4104.
Biologics Competition Act of 2023 This bill requires the Food and Drug Administration (FDA) to evaluate (1) the differences between the requirements that apply to interchangeable biologics and the requirements that apply to therapeutically equivalent ratings for generic drugs, and (2) the effects of these differences on the approval of interchangeable biologics. The FDA must update the Purple Book with changes that better align the ways these requirements are communicated while still maintaining each distinct approval pathway. The Purple Book is an FDA publication that lists approved biological products, including biosimilars and interchangeable biologics. Interchangeable biologics are biologics that may be substituted for the original product without consulting the prescriber, similar to how generic drugs may be substituted for brand-name drugs based on therapeutic equivalence.
Maddy summaryThis bill amends the Affordable Care Act to allow individuals to enroll in standalone dental plans through health insurance Exchanges without needing to also have a separate health insurance plan. It directly affects consumers seeking dental coverage who may not qualify for or prefer not to enroll in a comprehensive health plan. The key provision removes a federal restriction that previously prevented enrollment in these dental plans solely based on lack of separate health insurance. This change makes it easier for people to access dental insurance options through the same marketplaces used for health coverage.
